Gov. Pat McCrory has named three people to the board of the North Carolina Biotechnology Center.
The state-funded Biotech Center supports biotechnology research, business and education, the progress of biotechnology from research to commercialization in North Carolina. The center also supports the growth of biotechnology in North Carolina, including job growth.
Each of the board appointments is for two years. Art Pappas, founder of Durham venture capital firm Pappas Ventures, was reappointed to the board by McCrory. Joining Pappas on the Biotech Center’s board are Carol Marino, managing director for Syngenta Ventures, the venture arm of agricultural biotech company Syngenta and Dr. Bhaskar Venepalli, president and CEO of CiVentiChem, an R&D services company.
